Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018;66(1):25-36.
doi: 10.3233/JAD-180583.

Positive Feedback Loops in Alzheimer's Disease: The Alzheimer's Feedback Hypothesis

Affiliations
Review

Positive Feedback Loops in Alzheimer's Disease: The Alzheimer's Feedback Hypothesis

Andrew J Doig. J Alzheimers Dis. 2018.

Abstract

The dominant model for Alzheimer's disease (AD) is the amyloid cascade hypothesis, in which the accumulation of excess amyloid-β (Aβ) leads to inflammation, excess glutamate and intracellular calcium, oxidative stress, tau hyperphosphorylation and tangle formation, neuronal loss, and ultimately dementia. In a cascade, AD proceeds in a unidirectional fashion, with events only affecting downstream processes. Compelling evidence now exists for the presence of positive feedback loops in AD, however, involving oxidative stress, inflammation, glutamate, calcium, and tau. The pathological state of AD is thus a system of positive feedback loops, leading to amplification of the initial perturbation, rather than a linear cascade. Drugs may therefore be effective by targeting numerous points within the loops, rather than concentrating on upstream processes. Anti-inflammatories and anti-oxidants may be especially valuable, since these processes are involved in many loops and hence would affect numerous processes in AD.

Keywords: Aggregation; amyloid; amyloid-β protein precursor; directed acyclic graph; drug discovery; peptide; systems biology.

PubMed Disclaimer

Conflict of interest statement

The author’s disclosure is available online (https://www.j-alz.com/manuscript-disclosures/18-0583r2).

Figures

Fig.1
Fig.1
The Amyloid cascade.
Fig.2
Fig.2
Feedback Loops in the Amyloid Cascade. Blue arrows show pathways in healthy cells; black arrows show AD pathways; pathways activated in AD are in green; pathways inhibited in AD are in red. The dashed line shows a tentative connection from hyperphosphorylated τ to increased AβPP processing to Aβ.

Similar articles

Cited by

References

    1. Hardy JA, Higgins GA (1992) Alzheimer’s disease: The amyloid cascade hypothesis. Science 256, 184–185. - PubMed
    1. Jawhar S, Wirths O, Bayer TA (2011) Pyroglutamate amyloid-beta (A beta): A hatchet man in Alzheimer disease. J Biol Chem 286, 38825–38832. - PMC - PubMed
    1. Willem M, Tahirovic S, Busche MA, Ovsepian SV, Chafai M, Kootar S, Hornburg D, Evans LDB, Moore S, Daria A, Hampel H, Muller V, Giudici C, Nuscher B, Wenninger-Weinzierl A, Kremmer E, Heneka MT, Thal DR, Giedraitis V, Lannfelt L, Muller U, Livesey FJ, Meissner F, Herms J, Konnerth A, Marie H, Haass C (2015) Eta-Secretase processing of APP inhibits neuronal activity in the hippocampus. Nature 526, 443. - PMC - PubMed
    1. Roher AE, Kokjohn TA, Clarke SG, Sierks MR, Maarouf CL, Serrano GE, Sabbagh MS, Beach TG (2017) APP/A beta structural diversity and Alzheimer’s disease pathogenesis. Neurochem Int 110, 1–13. - PMC - PubMed
    1. Hunter S, Brayne C (2012) Relationships between the amyloid precursor protein and its various proteolytic fragments and neuronal systems. Alzheimers Res Therapy 4, 10. - PMC - PubMed

Publication types

MeSH terms